Home Industries Pharma FDC launches two favipiravir variants for COVID-19 treatment

FDC launches two favipiravir variants for COVID-19 treatment

National, August 26, 2020: FDC announced the launch of two variants of favipiravir – PiFLU and Favenza – which will be used to treat mild to moderate cases of COVID-19 in India.

Earlier this year, the Drug Controller General of India (DCGI) approved the use of favipiravir, an off-patent, oral anti-viral drug that has been shown to quicken clinical recovery in COVID-19 patients with mild to moderate symptoms. It is a broad-spectrum antiviral agent, and selectively inhibits RNA polymerase of influenza and SARCOV-2 virus and prevents viral replication according to the reports published in expresspharma.in.

Commenting on the development, spokesperson of FDC, Mayank Tikkha, said, “We will be working with the government and healthcare fraternity to make Favenza and Piflu available across the country”.

FDC’s PiFLU and Favenza is currently available across the country.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

- Advertisment -

Most Popular

Athletes given ‘anti-sex’ beds at Tokyo Olympics, hilarious reactions online

New Delhi, July 24, 2021: Cardboard-made ‘anti-sex’ beds provided to athletes to prevent intimacy at the Tokyo Games village has triggered a plethora of...

Indian Oil Recruitment 2021: Apply for Engineers and Officer posts, check dates, salary and other details

New Delhi, July 24, 2021: Indian Oil Corporation Recruitment 2021 process for various posts has begun and applications have been invited for the posts...

SRM University Andhra Pradesh Hiring Faculty Posts ! Salary at 12-36 Lakh Per Annum

Amaravati, July 21, 2021: SRM University Andhra Pradesh (AP), Amaravati, a private university of SRM Education Group, has announced faculty recruitment for its various...

SRM University AP Collaborates with Harvard Business School Online

Vijayawada, July 21, 2021: SRM University opens the gates to new opportunities for students, alumni & faculty members as it collaborates with the world-renowned...

Recent Comments